INFORMATION FOR
News
In a Q&A, Mireille Serlie, MD, PhD, discusses the effects of eating patterns on the brain, the risks of being frequently exposed to high-sucrose and high-fat foods, and recommendations for adopting healthy eating habits.
In a Q&A, Ania Jastreboff, MD, PhD, discusses the barriers to treating obesity, benefits of clinical trials, and the new era of obesity medicine.
Ania Jastreboff, MD, PhD, Director, Yale Obesity Research Center (Y-Weight); Co-Director, Yale Center for Weight Management, is interviewed by WTNH-TV on muscle loss while losing weight.
Low albumin levels were associated with an increased rate of serious surgical complications and comorbidities.
Kasia Lipska, MD, MHS, was one of five experts invited to testify at the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on December 14, 2023.
Bariatric surgeon Dr. Neil Floch speaks with Kate Bauman about the treatments surrounding obesity.
Patients who could benefit from popular obesity and Type 2 diabetes drugs are unable to get them due to disparities.
The SELECT trial findings suggest a weight loss drug could lower the risk of heart disease by 20 percent.
The shifts in attitude about obesity can also be seen in the KFF survey, said Dr. Ania Jastreboff, an endocrinologist and obesity-medicine specialist at Yale University and a consultant for the makers of the new drugs. After decades of hearing that losing weight was just a matter of exerting willpower, most of the public is intensely interested in medical treatments.
Rachel Perry, PhD, assistant professor of medicine (endocrinology) and of cellular and molecular physiology, received the Endocrinology and Metabolism Section New Investigator Award from the American Physiological Society (APS) during its summit on April 21.
Sedentary time at an extraordinary level. Harlan Krumholz, MD , says we need a large-scale societal shift where daily movement is the norm.
In today’s health headlines, what to know about a new Omicron subvariant, and how Americans are snacking more than ever. What this means for our health, and the link between asthma and obesity. Dr. Nate Wood, Yale Medicine Internal Medicine specialist and instructor at Yale School of Medicine, discussed these topics.
Millions of U.S. adults who are overweight or obese are unable to afford the latest treatment in obesity medicine, a study by the Yale School of Medicine has found.
Harlan Krumholz joins Shep Smith to discuss new recommendations regarding aspirin and heart disease, and diabetes testing for obese adults age 35 and over.
Samoa has one of the highest prevalences of childhood obesity in the world. The Samoa Observer reports on the results of Courtney Choy's Brown University Department of Epidemiology doctoral dissertation, which finds a clear need for intervention before a child turns five, especially for Samoan children in urban areas, eating what has become the now-normal diet of imported and packaged foods. Interrupting this lifestyle could be an effective way to prevent obesity and related cardiometabolic diseases, Choy finds.
The standard approach of assessing long-term risk for ASCVD works just as well for patients who are overweight as they do for patients at an optimal weight, according to a new study in JAMA Network Open.
Sugary soda and ultra-processed snacks go the way of cigarettes and booze, with a number of Mexican states banning them for minors.
Doctors who specialize in obesity say during a respiratory pandemic like COVID-19, keeping your weight under control can be a real lifesaver.
Several studies in recent years have reported that low-calorie sweeteners in foods and beverages disrupt the human metabolism, promoting the development of diabetes and obesity. But other studies have found that consuming low-calorie drinks and food has little impact on metabolism and might actually aid in weight loss. A new study by Yale researchers published March 3 in the journal Cell Metabolism may help reconcile these conflicting findings.
In obese individuals, cellular "doormen" open the gates far too wide in certain key fat cells, known as visceral fat cells, letting in too many carbohydrates without first burning off lipids. This leads to a ballooning of the size of visceral fat cells in the belly.